{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:06:38Z","timestamp":1789913198393,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T00:00:00Z","timestamp":1323907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s00417-011-1896-1","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T06:52:40Z","timestamp":1323845560000},"page":"871-877","source":"Crossref","is-referenced-by-count":6,"title":["Outcomes of toll-like receptors\u2019 antagonism in steroid-resistant optic neuritis; a pilot study"],"prefix":"10.1007","volume":"250","author":[{"given":"Aditya","family":"Sudhalkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuri","family":"Khamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakulesh","family":"Khamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,15]]},"reference":[{"issue":"9","key":"1896_CR1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","volume":"326","author":"RW Beck","year":"1992","unstructured":"Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR, Savino P, Guy J, Trobe J, McCrary-III J, Smith C, Chrousos G, Thompson SH, Katz B, Brodsky MC, Goodwin JA, Atwell CW; The Optic Neuritis Study Group (1992) A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 326(9):581\u2013588","journal-title":"N Engl J Med"},{"issue":"11","key":"1896_CR2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri1957","volume":"6","author":"AM Rothstein","year":"2006","unstructured":"Rothstein AM (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6(11):823\u2013835","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"1896_CR3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/emmm.201000103","volume":"2","author":"X Guo","year":"2010","unstructured":"Guo X, Harada C, Namekata K, Matsuzawa A, Camps M, Ji H, Swinnen D, Jorand-Lebrun C, Muzerelle M, Vitte PA, R\u00fcckle T, Kimura A, Kohyama K, Matsumoto Y, Ichijo H, Harada T (2010) Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway. EMBO Mol Med 2(12):504\u2013515","journal-title":"EMBO Mol Med"},{"key":"1896_CR4","first-page":"668.6","volume":"22","author":"K O\u2019Brien","year":"2008","unstructured":"O\u2019Brien K, Gran B (2008) Toll like receptors and autoimmune demylenating disorders; Special relevance to multiple sclerosis. FASEB J 22: 668.6","journal-title":"FASEB J"},{"issue":"6","key":"1896_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000127433","volume":"14","author":"YN Deng","year":"2007","unstructured":"Deng YN, Zhou WB (2007) Expression of TLR4 and TLR9 mRNA in Lewis rats with experimental allergic neuritis. Neuroimmunomodulation 14(6):337\u2013343","journal-title":"Neuroimmunomodulation"},{"issue":"6","key":"1896_CR6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/ana.22136","volume":"68","author":"KE Balashov","year":"2010","unstructured":"Balashov KE, Aung LL, Vaknin-Dembinsky A, Dhib-Jalbut S, Weiner HL (2010) Interferon-\u03b2 inhibits toll-like receptor 9 processing in multiple sclerosis. Ann Neurol 68(6):899\u2013906","journal-title":"Ann Neurol"},{"issue":"4","key":"1896_CR7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ana.22350","volume":"69","author":"H Zahednasab","year":"2011","unstructured":"Zahednasab H, Bahreini SA (2011) Interferon-beta and toll-like receptor-9 processing. Ann Neurol 69(4):740\u2013741. doi: 10.1002\/ana.22350 , author reply 741","journal-title":"Ann Neurol"},{"issue":"11","key":"1896_CR8","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1468-1331.2008.02258.x","volume":"15","author":"A Tselis","year":"2008","unstructured":"Tselis A, Perumal J, Caon C, Hreha S, Ching W, Din M, Van Stavern G, Khan O (2008) Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin. Eur J Neurol 15(11):1163\u20131167","journal-title":"Eur J Neurol"},{"issue":"11","key":"1896_CR9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1468-1331.2008.02257.x","volume":"15","author":"A Achiron","year":"2008","unstructured":"Achiron A (2008) Winning combination: the additive\/synergistic benefits of IVIg in corticosteroid refractory optic neuritis. Eur J Neurol 15(11):1145","journal-title":"Eur J Neurol"},{"key":"1896_CR10","doi-asserted-by":"crossref","unstructured":"Huchzermeyer C, Mardin C, Holbach L, Zwerina J, Schett G, Rech J (2010) Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener\u2019s granulomatosis. Clin Rheumatol Sep 23 [Epub ahead of print]","DOI":"10.1007\/s10067-010-1561-9"},{"issue":"1","key":"1896_CR11","first-page":"172","volume":"35","author":"CC Mok","year":"2008","unstructured":"Mok CC, To CH, Mak A, Poon WL (2008) Immunoablative cyclophosphamide for refractory lupus-related neuromyelitis optica. J Rheumatol 35(1):172\u2013174","journal-title":"J Rheumatol"},{"issue":"1","key":"1896_CR12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0002-9343(98)00372-6","volume":"106","author":"G Galindo-Rodr\u00edguez","year":"1999","unstructured":"Galindo-Rodr\u00edguez G, Avi\u00f1a-Zubieta JA, Pizarro S, D\u00edaz de Le\u00f3n V, Saucedo N, Fuentes M, Lavalle C (1999) Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosus: an open trial. Am J Med 106(1):65\u201369","journal-title":"Am J Med"},{"issue":"9","key":"1896_CR13","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archneurol.2009.175","volume":"66","author":"A Jacob","year":"2009","unstructured":"Jacob A, Matiello M, Weinshenker BG, Wingerchuk DM, Lucchinetti C, Shuster E, Carter J, Keegan BM, Kantarci OH, Pittock SJ (2009) Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol 66(9):1128\u20131133","journal-title":"Arch Neurol"},{"key":"1896_CR14","volume-title":"The chemotherapy source book","author":"MC Perry","year":"2007","unstructured":"Perry MC (2007) The chemotherapy source book, 4th edn. Lippincott, Williams and Wilkins, Philadelphia","edition":"4"},{"issue":"9","key":"1896_CR15","first-page":"559","volume":"101","author":"P Chaudhari","year":"2003","unstructured":"Chaudhari P, Mukhopadhyaya S (2003) Bladder preserving approach for muscle invasive bladder cancer--role of mycobacterium w. J Indian Med Assoc 101(9):559\u2013560","journal-title":"J Indian Med Assoc"},{"issue":"3","key":"1896_CR16","first-page":"174","volume":"70","author":"I Kaur","year":"2002","unstructured":"Kaur I, Dogra S, Kumar B, Radotra V (2002) Combined 12-month WHO\/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients. Int J Lepr Other Mycobact Dis 70(3):174\u2013181","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"1896_CR17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2133.2005.06286.x","volume":"152","author":"B Kumar","year":"2005","unstructured":"Kumar B, Sandhu K, Kaur I (2005) Role of Mycobacterium w vaccine in the management of psoriasis. Br J Dermatol 152:368\u2013403","journal-title":"Br J Dermatol"},{"issue":"16S Part 1","key":"1896_CR18","first-page":"521 s","volume":"23","author":"S Sarkar","year":"2005","unstructured":"Sarkar S, Dasgupta C (2005) Role of Mycobacterium W as an adjuvant treatment of head & neck cancer: a randomised trial. J Clinical Oncology 23(16S Part 1):521 s","journal-title":"J Clinical Oncology"},{"key":"1896_CR19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcrs.2004.01.014","volume":"30","author":"JT Holladay","year":"2004","unstructured":"Holladay JT (2004) Visual acuity measurements. J Cataract Refract Surg 30:287\u2013290","journal-title":"J Cataract Refract Surg"},{"key":"1896_CR20","unstructured":"Ishihara Instructions:The Series of PlatesDesigned as aTest for Color DeficiencySHINOBU ISHIHARA M.D., Dr.Med. Sc.Professor Emeritus of the University of TokyoMember of the Japan Academy24 Plates EditionKANEHARA TRADING INC.TOKYO \u00b7 JAPAN. www.dfisica.ubi.pt\/\u223chgil\/P.V.2\/Ishihara\/Ishihara.24.Plate.Instructions.I.pdf ; Accessed 30th July 2011"},{"issue":"11","key":"1896_CR21","first-page":"2278","volume":"38","author":"ME Schneck","year":"1997","unstructured":"Schneck ME, Haegerstrom-Portnoy G (1997) Colour vision defect type and spatial vision in optic neuritis. Invest Ophthalmol Vis Sci Oct 38(11):2278\u20132289","journal-title":"Invest Ophthalmol Vis Sci Oct"},{"key":"1896_CR22","unstructured":"Farnsworth D (1957) The Farnsworth-Munsell 100 Hue test for for the examination ofcolor discrimination. Munsell Color, New Windsor, NY, USA. http:\/\/qcqa.com\/docs\/doc2_2552.pdf . Accessed 30th July 2011"},{"key":"1896_CR23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0161-6420(87)33349-4","volume":"94","author":"JA Fleishman","year":"1987","unstructured":"Fleishman JA, Beck RW, Linares OA, Klein JW (1987) Defects in visual function after resolution of optic neuritis. Ophthalmology 94:102\u2013105","journal-title":"Ophthalmology"},{"issue":"1","key":"1896_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0022-510X(71)90205-X","volume":"13","author":"A Mathew","year":"1971","unstructured":"Mathew A, Mathai K, Abraham J, Taori GM (1971) Incidence and pattern of demyelinating disease in India. J Neurol Sci 13(1):27\u201338","journal-title":"J Neurol Sci"},{"key":"1896_CR25","volume-title":"Albert and Jackobiec\u2019s principles and practice of ophthalmology","author":"D Albert","year":"2008","unstructured":"Albert D, Azar D, Blodi B, Miller J (2008) Albert and Jackobiec\u2019s principles and practice of ophthalmology, 3rd edn. Saunders\u2013Elsevier, Philadelphia","edition":"3"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1896-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-011-1896-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1896-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T22:24:50Z","timestamp":1561069490000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-011-1896-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,15]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["1896"],"URL":"https:\/\/doi.org\/10.1007\/s00417-011-1896-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,15]]}}}